HOME Top Market Reports Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

By: marketsandmarkets.com
Publishing Date: November 2014
Report Code: BT 2910

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global synthetic biology market is segmented on the basis of tools, technologies, applications, and regions. Based on tools, the market is categorized into Xeno-nucleic acids, chassis organisms, oligonucleotides, enzymes, and cloning and assembly kits. Based on technologies, the synthetic biology market is segmented into enabling and enabled technologies, while on the basis of applications; the market is segmented into environmental, medical, and industrial applications.

Increasing R&D expenditure in pharmaceutical and biotechnology companies, growing demand for synthetic genes, rising production of genetically modified crops, and incessantly rising funding in the field of synthetic biology are the significant factors driving the market. However, ethical and socialissues such as biosafety and biosecurity are the major factors restraining the growth of this market. Furthermore, rising concerns over fuel consumption and increasing demand for protein therapeutics are likely to create opportunities for this market. However, standardization and integration of biological parts at system-level still remains a challenge for this market.

Some of the major players in the global synthetic biology market include Amyris, Inc. (U.S.), DuPont (U.S.), GenScript USA Inc. (U.S.), Intrexon Corporation (U.S.), Integrated DNA Technologies (IDT) (U.S.), New England Biolabs, Inc. (NEB) (U.S.), Novozymes (Denmark), Royal DSM (Netherlands), Synthetic Genomics, Inc. (California), and Thermo Fisher Scientific, Inc. (U.S.).

Scope of the Report

This research report categorizes the synthetic biology market into the following segments and subsegments:

By Tool

  • Xeno-nucleic Acids (XNA)
  • Oligonucleotides
  • Chassis Organisms
  • Enzymes
  • Cloning and Assembly kits

By Technology

  • Enabling Technologies
    • Bioinformatics
    • Gene Synthesis
    • Genome Engineering
    • Microfluidics
    • Measurement and Modeling
    • Nanotechnology
    • Cloning and Sequencing
    • Site-saturation Mutagenesis
  • Enabled Technologies
    • Pathway Engineering
    • Next-generation Sequencing

By Application

  • Environmental Application
    • Bioremediation
    • Whole-cell Biosensors
  • Medical Application
    • Artificial Tissue and Tissue Regeneration
    • Drug Discovery and Therapeutics
    • Pharmaceuticals
  • Industrial Application
    • Biofuels and Renewable Energy
    • Biomaterials and Green Chemicals
    • Industrial Enzymes

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Denmark
    • Switzerland
    • Rest of Europe
  • Asia
    • China
    • Japan
    • Rest of Asia
  • Rest of the World (RoW)

Table of Contents 
 
1 Introduction (Page No.16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Markets Covered
    1.4 Years Considered for the Study
    1.5 Currency
    1.6 Package Size
    1.7 Limitations
    1.8 Stakeholders

2 Research Methodology (Page No.19)
    2.1 Secondary and Primary Research Methodology
           2.1.1 Secondary Research
    2.2 Key Data From Secondary Sources
           2.2.1 Primary Research
    2.3 Key Data From Primary Sources
    2.4 Key Insights From Primary Sources
    2.5 Market Size Estimation Methodology
    2.6 Market forecast Methodology
    2.7 Market Data Validation and Data Triangulation
    2.8 Assumptions

3 Executive Summary (Page No.28)

4 Premium Insights (Page No.32)
    4.1 Global Synthetic Biology Market to Witness A High Cagr of 24% From 2013 to 2018
    4.2 Synthetic Biology Market, By Region and Application
    4.3 Geographic Snapshot
    4.4 Life Cycle Analysis, By Geography

5 Industry Speaks (Page No.36)
    5.1 Demand Side
    5.2 Supply Side

6 Market Overview (Page No.38)
    6.1 Introduction
    6.2 Market Dynamics
          6.2.1 Drivers
                   6.2.1.1 Rising R&D Expenditure of Pharmaceutical and Biotechnology Companies
                   6.2.1.2 Increasing Demand for Synthetic Genes
                   6.2.1.3 Rise in the Global Production of Genetically Modified Crops
                   6.2.1.4 Increase in Funding
          6.2.2 Restraint
                   6.2.2.1 Ethical and Societal Issues
          6.2.3 Challenge
                   6.2.3.1 Standardization of Biological Parts
          6.2.4 Opportunities
                   6.2.4.1 Rising Concerns on Fuel Consumption
                   6.2.4.2 Increasing Demand for Protein therapeutics

7 Industry Insights (Page No.45)
    7.1 Porter’s Five forces Analysis
          7.1.1 Threat of New Entrants
          7.1.2 Bargaining Power of Suppliers
          7.1.3 Bargaining Power of Buyers
          7.1.4 Segment Rivalry
          7.1.5 Threat of Substitutes

8 Synthetic Biology Market, By Tool (Page No.48)
    8.1 Introduction
    8.2 Xeno-Nucleic Acids (Xnas)
    8.3 Chassis Organisms
    8.4 Oligonucleotides
    8.5 Enzymes
    8.6 Cloning Technology Kits

9 Market, By Technology (Page No.57)
    9.1 Introduction
          9.1.1 Enabling Technologies
                   9.1.1.1 Gene Synthesis
                   9.1.1.2 Bioinformatics
                   9.1.1.3 Genome Engineering
                   9.1.1.4 Cloning and Sequencing
                   9.1.1.5 Site-Directed Mutagenesis (SDM)
                   9.1.1.6 Measurement and Modeling
                   9.1.1.7 Microfluidics
                   9.1.1.8 Nanotechnology
          9.1.2 Enabled Technologies
                   9.1.2.1 Pathway Engineering
                   9.1.2.2 Next-Generation Sequencing

10 Market, By Application (Page No.72)
     10.1 Introduction
             10.1.1 Environmental Applications
                        10.1.1.1 Bioremediation
                        10.1.1.2 Whole-Cell Biosensors
             10.1.2 Medical Applications
                        10.1.2.1 Drug Discovery and therapeutics
                        10.1.2.2 Pharmaceuticals
                        10.1.2.3 Artificial Tissue and Tissue Regeneration
             10.1.3 Industrial Applications
                        10.1.3.1 Biofuel & Renewable Energy
                        10.1.3.2 Industrial Enzymes
                        10.1.3.3 Biomaterials & Green Chemicals

11 Synthetic Biology Market, By Geography (Page No.87)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
                        11.2.1.1 Government Investments Propelling the Synthetic Biology Market in the U.S.
                        11.2.1.2 Increase in Number of Synthetic Biology Companies and Research Institutes Boosting U.S. Market
             11.2.2 Canada
                        11.2.2.1 Synthetic Biology-Related Conferences and Workshops Promoting Research Activities in Canada
     11.3 Europe
             11.3.1 Europe Prioritizing International Alliances to Boost Synthetic Biology Market
             11.3.2 Heavy Funding for Synthetic Biology Research Likely to Stimulate Market Growth in Europe
             11.3.3 U.K.
                        11.3.3.1 Strong Government Support for Synthetic Biology in the U.K.
             11.3.4 Germany
                        11.3.4.1 Strong Investments Driving the Synthetic Biology Market in Germany
             11.3.5 France
                        11.3.5.1 Rising Awareness to Boost Synthetic Biology Market Growth in France
             11.3.6 Denmark
             11.3.7 Switzerland
                        11.3.7.1 Switzerland Synthetic Biology Market Buoyed By Investments
             11.3.8 Rest of Europe (ROE)
     11.4 Asia
             11.4.1 China
                        11.4.1.1 Collaborations Related to Synthetic Biology Likely to Spur Innovation and Research in Synthetic Biology in China
                        11.4.1.2 Increasing Number of Conferences to Boost Awareness
             11.4.2 Japan
                        11.4.2.1 Established Biotechnology Industry Makes Japan the Leading Asian Country in this Market
             11.4.3 Rest of Asia (ROA)
                        11.4.3.1 Government Investments and Conferences Stimulating the Demand in the ROA
     11.5 Rest of the World (ROW)

12 Competitive Landscape (Page No.122)
     12.1 Overview
     12.2 Market Share Analysis
             12.2.1 Introduction
                        12.2.1.1 Thermo Fisher Scientific, Inc. (U.S.)
                        12.2.1.2 Royal DSM N.V. (Netherlands)
                        12.2.1.3 Dupont (U.S.)
     12.3 Competitive Situation and Trends
     12.4 Agreements, Partnerships, Collaborations, and Joint Ventures
     12.5 New Product Launches
     12.6 Expansions
     12.7 Acquisitions
     12.8 Others

13 Company Profiles (Page No.132)
     13.1 Introduction
     13.2 Amyris, Inc.
             13.2.1 Business Overview
             13.2.2 Amyris, Inc.: Company Snapshot
             13.2.3 Products
             13.2.4 Key Strategy
             13.2.5 Recent Developments
     13.3 Dupont
             13.3.1 Business Overview
             13.3.2 Services
             13.3.3 Key Strategy
             13.3.4 Recent Developments
             13.3.5 SWOT Analysis
     13.4 Genscript USA, Inc.
             13.4.1 Business Overview
             13.4.2 Financials
             13.4.3 Services
             13.4.4 Key Strategy
             13.4.5 Recent Developments
     13.5 Intrexon Corporation
             13.5.1 Business Overview
             13.5.2 Core Technologies
             13.5.3 Key Strategy
             13.5.4 Recent Developments
     13.6 Integrated Dna Technologies (IDT), Inc.
             13.6.1 Business Overview
             13.6.2 Financials
             13.6.3 Products
             13.6.4 Key Strategy
             13.6.5 Recent Developments
     13.7 New England Biolabs, Inc.
             13.7.1 Business Overview
             13.7.2 Financials
             13.7.3 Product Portfolio
             13.7.4 Key Strategy
             13.7.5 Recent Developments
     13.8 Novozymes
             13.8.1 Business Overview
             13.8.2 Novozymes: Company Snapshot
             13.8.3 Product Portfolio
             13.8.4 Key Strategy
             13.8.5 Recent Developments
             13.8.6 SWOT Analysis
     13.9 Royal DSM N.V.
             13.9.1 Business Overview
             13.9.2 Product Portfolio
             13.9.3 Key Strategy
             13.9.4 Recent Developments
             13.9.5 SWOT Analysis
     13.10 Synthetic Genomics, Inc.
             13.10.1 Business Overview
             13.10.2 Financials
             13.10.3 Products & Services
             13.10.4 Key Strategy
             13.10.5 Recent Developments
     13.11 Thermo Fisher Scientific, Inc.
             13.11.1 Business Overview
             13.11.2 Products & Services
             13.11.3 Key Strategy
             13.11.4 Recent Developments
             13.11.5 SWOT Analysis

14 Appendix (Page No.176)
     14.1 Discussion Guide
     14.2 Introducing RT: Real-Time Market Intelligence
     14.3 Available Customizations
     14.4 Related Reports 
 
List of Tables (99 Tables) 
  
Table 1 Increasing Demand for Synthetic Genes Propelling Market Growth
Table 2 Ethical and Societal Issues Such As Biosafety and Biosecurity Restraint Market Growth
Table 3 Standardization of Biological Parts is A Major Challenge Faced By Synthetic Biology Market Players 
Table 4 Rising Concerns About Fuel Consumption is A Major Growth Opportunity in the Global Market
Table 5 Synthetic Biology Market Size, By Segment, 2012–2018 ($Million)
Table 6 Market Size, By Tool, 2012–2018 ($Million)
Table 7 Synthetic Biology Tools Market Size, By Region, 2012–2018 ($Million)
Table 8 Market Size for Xeno-Nucleic Acids, By Region, 2012–2018 ($Million) 
Table 9 Market Size for Chassis Organisms, By Region, 2012–2018 ($Million) 
Table 10 Synthetic Biology Market Size for Oligonucleotides, By Region, 2012–2018 ($Million) 
Table 11 Market Size for Enzymes, By Region, 2012–2018 ($Million) 
Table 12 Market Size for Cloning Technology Kits, By Region,2012–2018 ($Million)
Table 13 Synthetic Biology Technologies Market Size, By Region, 2012-2018 ($Million) 
Table 14 Synthetic Biology Market Size, By Technology, 2012-2018 ($Million)
Table 15 Market Size for Enabling Technologies, By Region,2012-2018 
Table 16 Market Size for Enabling Technologies, By Segment,2012-2018 
Table 17 Synthetic Biology Market Size for Gene Synthesis, By Region, 2012-2018 ($Million) 
Table 18 Market for Bioinformatics, By Region, 2012-2018 ($Million) 
Table 19 Synthetic Biology Market Size for Genome Engineering, By Region,2012-2018 ($Million) 
Table 20 Market Size for Cloning and Sequencing, By Region,2012-2018 ($Million) 
Table 21 Market Size for Site-Directed Mutagenesis, By Region, 2012-2018 ($Million) 
Table 22 Market Size for Measurement and Modeling, By Region, 2012-2018 ($Million) 
Table 23 Synthetic Biology Market Size for Microfluidics, By Region, 2012-2018 ($Million) 
Table 24 Market Size for Nanotechnology, By Region, 2012-2018 ($Million) 
Table 25 Synthetic Biology Market Size for Enabled Technologies, By Region,2012-2018 ($Million) 
Table 26 Synthetic Biology Market Size for Enabled Technologies, By Segment,2012-2018 ($Million) 
Table 27 Market Size for Pathway Engineering, By Region,2012-2018 ($Million) 
Table 28 Market Size for Next-Generation Sequencing, By Region, 2012-2018 ($Million) 
Table 29 Synthetic Biology Applications Market Size, By Region, 2012–2018 ($Million) 
Table 30 Synthetic Biology Market Size, By Application, 2012–2018 ($Million)
Table 31 Market Size for Environmental Applications, By Region, 2012–2018 
Table 32 Market Size for Environmental Applications, By Segment, 2012–2018 ($Million) 
Table 33 Market Size for Bioremediation, By Region, 2012–2018 ($Million) 
Table 34 Market Size for Whole-Cell Biosensors, By Region,2012–2018 ($Million) 
Table 35 Market Size for Medical Applications, By Region,2012–2018 ($Million) 
Table 36 Synthetic Biology Market Size for Medical Applications, By Segment,2012–2018 ($Million) 
Table 37 Market Size for Drug Discovery and Therapeutics, By Region, 2012–2018 ($Million) 
Table 38 Market Size for Pharmaceuticals, By Region, 2012–2018 ($Million) 
Table 39 Market Size for Artificial Tissue and Tissue Regeneration, By Region, 2012–2018 ($Million)
Table 40 Market Size for Industrial Applications, By Region,2012–2018 ($Million) 
Table 41 Synthetic Biology Market Size for Industrial Applications, By Segment,2012–2018 ($Million) 
Table 42 Market Size for Biofuel and Renewable Energy, By Region, 2012–2018 ($Million) 
Table 43 Market Size for Industrial Enzymes, By Region,2012–2014 ($Million)
Table 44 Market Size for Biomaterials and Green Chemicals,By Region, 2012–2018 ($Million)
Table 45 Synthetic Biology Market Size, By Region, 2012–2018 ($Million)
Table 46 North America: Market Size, By Country, 2012–2018 ($Million) 
Table 47 North America: Market Size, By Segment, 2012–2018 ($Million) 
Table 48 North America: Synthetic Biology Tools Market Size, 2012–2018 ($Million) 
Table 49 North America: Synthetic Biology Technologies Market Size, 2012–2018 ($Million) 
Table 50 North America: Synthetic Biology Enabling Technologies Market Size,2012–2018 ($Million)
Table 51 North America: Synthetic Biology Enabled Technologies Market Size,2012–2018 ($Million)
Table 52 North America: Market Size, By Application, 2012–2018 ($Million) 
Table 53 U.S.: Synthetic Biology Market Size, By Segment, 2012–2018 ($Million)
Table 54 U.S.: Market Size, By Application, 2012–2018 ($Million) 
Table 55 Canada: Market Size, By Segment, 2012–2018 ($Million) 
Table 56 Canada: Market Size, By Application, 2012–2018 ($Million) 
Table 57 Europe: Market Size, By Country, 2012–2018 ($Million) 
Table 58 Europe: Market Size, By Segment, 2012–2018 ($Million) 
Table 59 Europe: Synthetic Biology Tools Market Size, 2012–2018 ($Million)
Table 60 Europe: Synthetic Biology Technologies Market Size, 2012–2018 ($Million) 
Table 61 Europe: Synthetic Biology Enabling Technologies Market Size, 2012–2018 ($Million) 
Table 62 Europe: Synthetic Biology Enabled Technologies Market Size, 2012–2018 ($Million) 
Table 63 Europe: Market Size, By Application, 2012–2018 ($Million) 
Table 64 U.K.: Market Size, By Segment, 2012–2018 ($Million)
Table 65 U.K.: Market Size, By Application, 2012–2018 ($Million) 
Table 66 Germany: Market Size, By Segment, 2012–2018 ($Million) 
Table 67 Germany: Market Size, By Application, 2012–2018 ($Million) 
Table 68 France: Market Size, By Segment, 2012–2018 ($Million) 
Table 69 France: Market Size, By Application, 2012–2018 ($Million) 
Table 70 Denmark: Market Size, By Segment, 2012–2018 ($Million) 
Table 71 Denmark: Market Size, By Application, 2012–2018 ($Million) 
Table 72 Switzerland: Market Size, By Segment, 2012–2018 ($Million) 
Table 73 Switzerland: Market Size, By Application, 2012–2018 ($Million) 
Table 74 ROE: Market Size, By Segment, 2012–2018 ($Million)
Table 75 ROE: Market Size, By Application, 2012–2018 ($Million) 
Table 76 Asia: Market Size, By Country, 2012–2018 ($Million)
Table 77 Asia: Market Size, By Segment, 2012–2018 ($Million)
Table 78 Asia: Synthetic Biology Tools Market Size, 2012–2018 ($Million)
Table 79 Asia: Synthetic Biology Technologies Market Size, 2012–2018 ($Million)
Table 80 Asia: Synthetic Biology Enabling Technologies Market Size, 2012–2018 ($Million) 
Table 81 Asia: Synthetic Biology Enabled Technologies Market Size, 2012–2018 ($Million) 
Table 82 Asia: Market Size, By Application, 2012–2018 ($Million) 
Table 83 China: Market Size, By Segment, 2012–2018 ($Million)
Table 84 China: Market Size, By Application, 2012–2018 ($Million) 
Table 85 Japan: Market Size, By Segment, 2012–2018 ($Million)
Table 86 Japan: Market Size, By Application, 2012–2018 ($Million) 
Table 87 ROA: Market Size, By Segment, 2012–2018 ($Million)
Table 88 ROA: Market Size, By Application, 2012–2018 ($Million) 
Table 89 ROW: Market Size, By Segment, 2012–2018 ($Million)
Table 90 ROW: Synthetic Biology Tools Market Size, 2012–2018 ($Million)
Table 91 ROW: Synthetic Biology Technologies Market Size, 2012–2018 ($Million)
Table 92 ROW: Synthetic Biology Enabling Technologies Market Size, 2012–2018 ($Million) 
Table 93 ROW: Synthetic Biology Enabled Technologies Market Size, 2012–2018 ($Million) 
Table 94 ROW: Market Size, By Application, 2012–2018 ($Million) 
Table 95 Agreements, Partnerships, Collaborations, and Joint Ventures, 2011–2014 
Table 96 New Product Launches, 2011–2013
Table 97 Expansions, 2011–2014
Table 98 Acquisitions, 2011–2014
Table 99 Others, 2011–2014 
  
List of Figures (46 Figures) 
 
Figure 1 Market Segmentation
Figure 2  Research Methodology Steps
Figure 3 Sampling Frame: Primary Research
Figure 4 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Size Estimation Methodology: Bottom-Up Approach
Figure 6 Market Size Estimation Methodology: Top-Down Approach
Figure 7 Market forecast Methodology
Figure 8 Data Triangulation Methodology
Figure 9 Market Snapshot, By Segment,2013–2018
Figure 10 Enabling Technologies Market Segment to Witness Highest Cagr of 24.8% From 2013 to 2018
Figure 11 Global Synthetic Biology Market, By Application 2013
Figure 12 Global Market, By Geography, 2013
Figure 13 Market Overview
Figure 14 North America to Dominate the Synthetic Biology Market in 2013
Figure 15 Europe to Witness the Highest Cagr During the forecast Period
Figure 16 Global Market to Witness Significant Growth in the Coming Years
Figure 17 Increasing Demand for Synthetic Genes to Spur Market Growth
Figure 18 Porter’s Five forces Analysis
Figure 19 Technologies Segment to Grow At A Higher Pace in forecast Period
Figure 20 Europe to Be the Fastest-Growing Market, By tool From 2013 to 2018 
Figure 21 Oligonucleotides Segment Commanded Largest Market Share in 2013
Figure 22 Synthetic Biology Technologies Market, 2013 Vs. 2018
Figure 23 Synthetic Biology Technology Market in Europe to Grow At Highest Cagr in forecast Period
Figure 24 Enabling Technologies Segment to Grow At Higher Cagr of 24.8%
Figure 25 Bioinformatics Segment to Grow At Highest Cagr of 26.2% in forecast Period
Figure 26 Next-Generation Sequencing to Grow At Higher Cagr of 24.9%
Figure 27 Synthetic Biology Applications Market, 2013 Vs. 2018
Figure 28 Medical to Grow At the Highest Cagr in the Global Synthetic Biology Applications Market
Figure 29 Bioremediation to Grow At the Highest Cagr of 23%
Figure 30 Drug Discovery and therapeutics Segment to Grow At the Highest Cagr 80
Figure 31 Biofuel and Renewable Energy Segment Accounted for A Share of 53% of the Synthetic Biology Market in 2013
Figure 32 Synthetic Biology Market in Europe to Grow At Highest Cagr (25.4%) From 2013 to 2018
Figure 33 North America Accounted for Largest Share of 43% of Synthetic Biology Market (2013)
Figure 34 U.K. to Be the Fastest-Growing Market in Europe
Figure 35 Companies Adopted Agreements, Partnerships, Collaborations, and Joint Ventures As Key Growth Strategy in Last Three Years
Figure 36 Market Share Analysis, By Key Player, 2013
Figure 37 Battle for Market Share: Expansion Was the Key Strategy
Figure 38 Geographical Revenue Mix of Top 4 Players
Figure 39 Dupont: Company Snapshot
Figure 40 Genscript USA Inc.: Company Snapshot
Figure 41 Intrexon Corporation : Company Snapshot
Figure 42 Integrated Dna Technologies (IDT): Company Snapshot
Figure 43 New England Biolabs, Inc.: Company Snapshot
Figure 44 Company Snapshot
Figure 45 Synthetic Genomics, Inc.: Company Snapshot
Figure 46 Company Snapshot 

The synthetic biology market is highly competitive with a large number of players, including both big and small players, operating in this market. Synthetic biology is an emerging area of research and is broadly described as the design and construction of novel organisms or devices, artificial biological pathways, and the redesign of existing natural biological systems.

The global synthetic biology market is segmented on the basis of tools, technologies, applications, and regions. On the basis of tools, the market is categorized into Xeno-nucleic acids, chassis organisms, oligonucleotides, enzymes, and cloning and assembly kits. The oligonucleotides segment is expected to account for the largest share of the synthetic biology market, by tool. However, the cloning and assembly kits segment is expected to grow at the fastest rate in the market, by tool.

On the basis of technologies, the synthetic biology market is segmented into enabling and enabled technologies. Enabling technologies account is the largest and fastest-growing segment of the market, by technology.

On the basis of applications, the synthetic biology market is segmented into environmental, medical, and industrial applications. Medical application is the largest (2013) and fastest-growing segment of the market, by application.

The key factors that are expected to spur the growth of this market are increasing R&D expenditure in pharmaceutical and biotechnology companies, growing demand for synthetic genes, rising production of genetically modified crops, and incessantly rising funding in this field. However, ethical and social issues such as biosafety and biosecurityof synthetic biology are hindering the growth of this market.

On the basis of region, this market is segmented into North America, Europe, Asia, andthe Rest of the World (RoW).

Global Synthetic Biology Market Size, by Region, 2013 - 2018

Synthetic Biology Market

Source: MarketsandMarkets Analysis

The global synthetic biology market is expected to reach $5,630.4 million in 2018 from $1,923.1 million in 2013, growing at a CAGR of 24%. The market is dominated byNorth America, followed by Europe, Asia, and Rest of the World (RoW). Europe is expected to dominate the market in terms of the value by 2018.

Some of the major players in the global market include Amyris, Inc. (U.S.), DuPont (U.S.), GenScript USA Inc. (U.S.), Intrexon Corporation (U.S.), Integrated DNA Technologies (IDT) (U.S.), New England Biolabs, Inc. (NEB) (U.S.), Novozymes (Denmark), Royal DSM (Netherlands), Synthetic Genomics, Inc. (California), and Thermo Fisher Scientific, Inc. (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo